{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:29:12Z","timestamp":1783067352571,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.thromres.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T16:32:46Z","timestamp":1364315566000},"page":"e202-e209","source":"Crossref","is-referenced-by-count":21,"title":["Hemodialysis duration, Human platelet antigen HPA-3 and IgA Isotype of anti-\u03b22glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients"],"prefix":"10.1016","volume":"131","author":[{"given":"Samira","family":"Hadhri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ben","family":"Rejeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Belarbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellatif","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadef","family":"Skouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.03.003_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccl.2005.04.004","article-title":"Vascular access in hemodialysis: issues, managements, and emerging concepts","volume":"23","author":"Roy-Chaudhury","year":"2005","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.thromres.2013.03.003_bb0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11239-008-0216-z","article-title":"Thrombophilias and arteriovenous fistula dysfunction in maintenance hemodialysis","volume":"27","author":"Danis","year":"2009","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2013.03.003_bb0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1055\/s-0031-1297373","article-title":"Thrombosis and occlusion of vascular access in hemodialyzed patients","volume":"37","author":"Montagnana","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.03.003_bb0020","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2004110999","article-title":"Thrombophilia and the risk for hemodialysis vascular access thrombosis","volume":"16","author":"Knoll","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.thromres.2013.03.003_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2009.11.022","article-title":"Simoes e Silva AC, Borges KB, Dusse LM. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis","volume":"411","author":"Rios","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.thromres.2013.03.003_bb0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0272-6386(03)00860-6","article-title":"Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation","volume":"42","author":"Nampoory","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.thromres.2013.03.003_bb0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1523-1755.2005.00515.x","article-title":"In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis","volume":"68","author":"Molino","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.thromres.2013.03.003_bb0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1742-1241.2005.00493.x","article-title":"Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis","volume":"59","author":"Chuang","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.thromres.2013.03.003_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcla.21506","article-title":"Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors","volume":"26","author":"Hadhri","year":"2012","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.thromres.2013.03.003_bb0050","first-page":"894","article-title":"Antibodies to anionic phospholipids and cofactors in kala-azar. Comparative study with malaria, toxoplasmosis and \"autoimmune diseases\"","volume":"26","author":"Skouri","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.thromres.2013.03.003_bb0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ajh.21735","article-title":"Comparaison of characteristics from White- and Black-Americans with venous thromboembolism: a cross sectional study","volume":"85","author":"Heit","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2013.03.003_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.03.003_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","article-title":"British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome","volume":"157","author":"Keeling","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.03.003_bb0070","first-page":"1137","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.03.003_bb0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ajh.20614","article-title":"A prospective study of the prevalence of heparin-induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis","volume":"81","author":"Skouri","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2013.03.003_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-0039.2010.01503.x","article-title":"Gene frequencies of the HPA-1 to -6 and -15 human platelet antigens in Tunisian blood donors","volume":"76","author":"Hadhri","year":"2010","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.thromres.2013.03.003_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/107602960300900107","article-title":"Atherosclerotic and hemostatic abnormalities in patients undergoing hemodialysis","volume":"9","author":"Kushiya","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.03.003_bb0090","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1297-9562(06)80020-3","article-title":"Antithrombine deficit and continuous renal replacement therapy","volume":"27","author":"Joannes-Boyau","year":"2006","journal-title":"ITBM-RBM"},{"key":"10.1016\/j.thromres.2013.03.003_bb0095","doi-asserted-by":"crossref","first-page":"e12280","DOI":"10.1371\/journal.pone.0012280","article-title":"IgA anti-\u03b22-glycoprotein I antibodies are associated with in increased risk of thromboboembolic events in patients with systemic lupus erythematosus","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2013.03.003_bb0100","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0961203308093460","article-title":"IgA antiphospholipid antibodies are an independent risk factor for thromboses","volume":"17","author":"Shen","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2013.03.003_bb0105","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203309103048","article-title":"Isolated elevation of IgA anti-\u03b22glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients","volume":"18","author":"Kumar","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2013.03.003_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.autrev.2012.08.002","article-title":"The clinical relevance of IgA anticardiolopin and IgA anti-\u03b22 glycoprotein I antiphospholipid antibodies: A systematic review","volume":"12","author":"Meijide","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.thromres.2013.03.003_bb0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2249.1999.01007.x","article-title":"Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype","volume":"117","author":"Lakos","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.thromres.2013.03.003_bb0120","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ki.2011.477","article-title":"IgA antibodies against \u03b22 glycoprotein I in hemodialysis patients are an independent risk factor for mortality","volume":"81","author":"Serrano","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.thromres.2013.03.003_bb0125","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ki.2012.35","article-title":"Does IgA antibody against \u03b22 glycoprotein I increase cardiovascular risk in hemodialysis patients?","volume":"81","author":"Patel","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.thromres.2013.03.003_bb0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.semarthrit.2006.01.001","article-title":"Antiphospholipid syndrome and the kidneys","volume":"35","author":"Uthman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.thromres.2013.03.003_bb0135","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/j.1538-7836.2005.01359.x","article-title":"Pathophysiology of the antiphospholipid syndrome","volume":"3","author":"de Groot","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.03.003_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jaut.2010.06.015","article-title":"A novel mechanism of thrombosis in antiphospholipid antibody syndrome","volume":"35","author":"Vlachoyiannopoulos","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.thromres.2013.03.003_bb0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3349\/ymj.2004.45.3.428","article-title":"Association of the gene polymorphisms of platelet glycoprotein Ia and IIb\/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population","volume":"45","author":"Park","year":"2004","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.thromres.2013.03.003_bb0150","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/01.STR.30.12.2606","article-title":"Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke","volume":"30","author":"Carter","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2013.03.003_bb0155","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/01.STR.31.7.1628","article-title":"Genetic variants of platelet glycoprotein receptors and risk of stroke in young women","volume":"31","author":"Reiner","year":"2000","journal-title":"Stroke"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481300090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481300090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T14:31:12Z","timestamp":1539786672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481300090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S004938481300090X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.03.003","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}